Hazard ratio of overall cancer and pancreatic cancer among exclusive users of insulin glargine vs. intermediate/long-acting human insulin (HI) users.

aExtended Cox model with time-varying insulin glargine and HI use, controlling for baseline propensity score.
bExtended Cox model with time-varying insulin glargine and HI use, controlling for baseline propensity score and time-varying use of insulin detemir (binary), mean daily dosage of fast-acting insulins, sulfonylurea, and metformin (in quartiles).